These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 21939723

  • 21. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.
    Bomsel M, Tudor D, Drillet AS, Alfsen A, Ganor Y, Roger MG, Mouz N, Amacker M, Chalifour A, Diomede L, Devillier G, Cong Z, Wei Q, Gao H, Qin C, Yang GB, Zurbriggen R, Lopalco L, Fleury S.
    Immunity; 2011 Feb 25; 34(2):269-80. PubMed ID: 21315623
    [Abstract] [Full Text] [Related]

  • 22. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.
    Dong XN, Xiao Y, Chen YH.
    Immunol Lett; 2001 Jan 01; 75(2):149-52. PubMed ID: 11137140
    [Abstract] [Full Text] [Related]

  • 23. Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes.
    Srivastava I, Goodsell A, Zhou F, Sun Y, Burke B, Barnett S, Vajdy M.
    Vaccine; 2008 May 23; 26(22):2796-806. PubMed ID: 18440102
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
    Chomont N, Hocini H, Gody JC, Bouhlal H, Becquart P, Krief-Bouillet C, Kazatchkine M, Bélec L.
    Virology; 2008 Jan 20; 370(2):246-54. PubMed ID: 17920650
    [Abstract] [Full Text] [Related]

  • 31. Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.
    Pastori C, Tudor D, Diomede L, Drillet AS, Jegerlehner A, Röhn TA, Bomsel M, Lopalco L.
    Virology; 2008 Jan 20; 431(1-2):1-11. PubMed ID: 22658900
    [Abstract] [Full Text] [Related]

  • 32. The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41.
    Wang Z, Liu Z, Cheng X, Chen YH.
    Microbiol Immunol; 2005 Jan 20; 49(8):703-9. PubMed ID: 16113499
    [Abstract] [Full Text] [Related]

  • 33. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J, Walther-Jallow L, Laurén A, Mäkitalo B, Oberg M, Wahren B, Fenyö EM, Spetz AL.
    Vaccine; 2009 Oct 30; 27(46):6424-31. PubMed ID: 19549607
    [Abstract] [Full Text] [Related]

  • 34. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
    Mohan T, Verma P, Rao DN.
    Immunobiology; 2014 Apr 30; 219(4):292-301. PubMed ID: 24290973
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope.
    Arnold GF, Velasco PK, Holmes AK, Wrin T, Geisler SC, Phung P, Tian Y, Resnick DA, Ma X, Mariano TM, Petropoulos CJ, Taylor JW, Katinger H, Arnold E.
    J Virol; 2009 May 30; 83(10):5087-100. PubMed ID: 19279101
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate.
    Chakrabarti BK, Ling X, Yang ZY, Montefiori DC, Panet A, Kong WP, Welcher B, Louder MK, Mascola JR, Nabel GJ.
    Vaccine; 2005 May 16; 23(26):3434-45. PubMed ID: 15837367
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.